ERCC1, as Prognostic and Predictive Marker in Metastatic Colorectal Cancer Patients Treated with Oxaliplatin based Chemotherapy

Anti-Epithelial Growth Factor Receptors for Prognosis in Management of Metastatic Colorectal Cancer

PD-L1 Expression in Colorectal Cancer and Its Relation to Microsatellite Instability and Cytotoxic Tumor-Infiltrating Lymphocytes

PD-L1 Expression in Colorectal Cancer and Its Relation to Microsatellite Instability and Cytotoxic Tumor-Infiltrating Lymphocytes

Prognostic Value of HER2 in Metastatic Colorectal Cancer: A Single Institutional Experience

The Effect of Primary Tumor Site on Survival in Metastatic Colorectal Cancer Patients and their Relation to KRAS and Biological Therapy

Study Of Biomarkers In Colorectal Cancer Invasion To The Liver

Does the number of metastatic organ involvement affect the response to irinotecan-based chemotherapy in patients with metastatic colorectal

Expression and Potential Prognostic Significance of CXCL12 and Aldolase A (ALDOA) in Colorectal Carcinoma: An Immunohistochemical Study

The Prognostic Value of Cancer Stem Cell Marker, Cluster of Differentiation 133 Expression in Stage III Colorectal Carcinoma